- Home
- Publications
- Publication Search
- Publication Details
Title
Src: Marker or Actor in Prostate Cancer Aggressiveness
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 4, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2014-08-18
DOI
10.3389/fonc.2014.00222
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of epithelial plasticity in prostate cancer dissemination and treatment resistance
- (2014) Rhonda L. Bitting et al. CANCER AND METASTASIS REVIEWS
- A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients
- (2014) Anna Spreafico et al. INVESTIGATIONAL NEW DRUGS
- Pharmacokinetic interactions of dasatinib and docetaxel
- (2014) Dominique Levêque LANCET ONCOLOGY
- SNAI1 is critical for the aggressiveness of prostate cancer cells with low E-cadherin
- (2014) Gagan Deep et al. Molecular Cancer
- A phase II trial of dasatinib in patients with metastatic castration-resistant prostate cancer treated previously with chemotherapy
- (2013) Przemyslaw W. Twardowski et al. ANTI-CANCER DRUGS
- A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancer
- (2013) Emmanuel S. Antonarakis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Osteoblasts stimulate the osteogenic and metastatic progression of castration-resistant prostate cancer in a novel model for in vitro and in vivo studies
- (2013) Malin Hagberg Thulin et al. CLINICAL & EXPERIMENTAL METASTASIS
- Ligand-independent activation of MET through IGF-1/IGF-1R signaling
- (2013) Andreas Varkaris et al. INTERNATIONAL JOURNAL OF CANCER
- Dasatinib and docetaxel in advanced prostate cancer
- (2013) Primo N Lara et al. LANCET ONCOLOGY
- Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial
- (2013) John C Araujo et al. LANCET ONCOLOGY
- α-santalol inhibits the angiogenesis and growth of human prostate tumor growth by targeting vascular endothelial growth factor receptor 2-mediated AKT/mTOR/P70S6K signaling pathway
- (2013) Sarita Saraswati et al. Molecular Cancer
- Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism
- (2013) Salida Mirzoeva et al. MOLECULAR CARCINOGENESIS
- miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT
- (2013) C-J Kao et al. ONCOGENE
- The role of DAB2IP in androgen receptor activation during prostate cancer progression
- (2013) K Wu et al. ONCOGENE
- CTA095, a Novel Etk and Src Dual Inhibitor, Induces Apoptosis in Prostate Cancer Cells and Overcomes Resistance to Src Inhibitors
- (2013) Wenchang Guo et al. PLoS One
- Src controls castration recurrence of CWR22 prostate cancer xenografts
- (2013) Bing Su et al. Cancer Medicine
- Long-term use of dasatinib in patients with metastatic castration-resistant prostate cancer after receiving the combination of dasatinib and docetaxel
- (2013) John Araujo et al. Cancer Management and Research
- miR-23b Represses Proto-oncogene Src Kinase and Functions as Methylation-Silenced Tumor Suppressor with Diagnostic and Prognostic Significance in Prostate Cancer
- (2012) S. Majid et al. CANCER RESEARCH
- Loss of Receptor Protein Tyrosine Phosphatase β/ζ (RPTPβ/ζ) Promotes Prostate Cancer Metastasis
- (2012) Zoi Diamantopoulou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression
- (2012) J. M. Drake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroendocrine-derived peptides promote prostate cancer cell survival through activation of IGF-1R signaling
- (2012) John O. DaSilva et al. PROSTATE
- Metastatic Progression of Prostate Cancer and E-Cadherin
- (2011) Aaron P. Putzke et al. AMERICAN JOURNAL OF PATHOLOGY
- Dasatinib combined with docetaxel for castration-resistant prostate cancer
- (2011) John C. Araujo et al. CANCER
- Dasatinib inhibits both osteoclast activation and prostate cancer PC-3 cell-induced osteoclast formation
- (2011) John C. Araujo et al. CANCER BIOLOGY & THERAPY
- Role of E-cadherin in Antimigratory and Antiinvasive Efficacy of Silibinin in Prostate Cancer Cells
- (2011) G. Deep et al. Cancer Prevention Research
- 1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway
- (2011) X. Pang et al. CARCINOGENESIS
- Impact of the SRC inhibitor dasatinib on the metastatic phenotype of human prostate cancer cells
- (2011) Lori Rice et al. CLINICAL & EXPERIMENTAL METASTASIS
- Ligand-dependent Corepressor Acts as a Novel Androgen Receptor Corepressor, Inhibits Prostate Cancer Growth, and Is Functionally Inactivated by the Src Protein Kinase
- (2011) Mohammad Asim et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Novel Membrane-associated Androgen Receptor Splice Variant Potentiates Proliferative and Survival Responses in Prostate Cancer Cells
- (2011) Xi Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- (-)-Gossypol Suppresses the Growth of Human Prostate Cancer Xenografts via Modulating VEGF Signaling-Mediated Angiogenesis
- (2011) X. Pang et al. MOLECULAR CANCER THERAPEUTICS
- Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
- (2011) Jones T. Nauseef et al. Nature Reviews Urology
- Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal
- (2011) S. Memarzadeh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Differential transformation capacity of Src family kinases during the initiation of prostate cancer
- (2011) H. Cai et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Once-daily Dasatinib: Expansion of Phase II Study Evaluating Safety and Efficacy of Dasatinib in Patients With Metastatic Castration-resistant Prostate Cancer
- (2011) Evan Y. Yu et al. UROLOGY
- Invasive Prostate Carcinoma Driven by c-Src and Androgen Receptor Synergy
- (2010) H. Cai et al. CANCER RESEARCH
- Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo
- (2010) Lei Gu et al. ENDOCRINE-RELATED CANCER
- Src kinase inhibitors: an emerging therapeutic treatment option for prostate cancer
- (2010) Joanne Edwards EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Src signaling in cancer invasion
- (2010) Marcello Guarino JOURNAL OF CELLULAR PHYSIOLOGY
- SKI-606 (Bosutinib) Blocks Prostate Cancer Invasion, Growth, and Metastasis In vitro and In vivo through Regulation of Genes Involved in Cancer Growth and Skeletal Metastasis
- (2010) S. A. Rabbani et al. MOLECULAR CANCER THERAPEUTICS
- Effect of the Specific Src Family Kinase Inhibitor Saracatinib on Osteolytic Lesions Using the PC-3 Bone Model
- (2010) J. C. Yang et al. MOLECULAR CANCER THERAPEUTICS
- Src family kinase/abl inhibitor dasatinib suppresses proliferation and enhances differentiation of osteoblasts
- (2010) Y-C Lee et al. ONCOGENE
- Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases
- (2010) Y Liu et al. ONCOGENE
- A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study
- (2009) Primo N. Lara et al. ANTI-CANCER DRUGS
- Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis
- (2009) T Koreckij et al. BRITISH JOURNAL OF CANCER
- The Neuroendocrine-Derived Peptide Parathyroid Hormone-Related Protein Promotes Prostate Cancer Cell Growth by Stabilizing the Androgen Receptor
- (2009) J. DaSilva et al. CANCER RESEARCH
- Acetyl-11-Keto- -Boswellic Acid Inhibits Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2-Mediated Angiogenesis
- (2009) X. Pang et al. CANCER RESEARCH
- SRC kinase inhibition: Targeting bone metastases and tumor growth in prostate and breast cancer
- (2009) Fred Saad et al. CANCER TREATMENT REVIEWS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
- (2009) E. Y. Yu et al. CLINICAL CANCER RESEARCH
- Src Family Kinase Activity Is Up-Regulated in Hormone-Refractory Prostate Cancer
- (2009) O. Tatarov et al. CLINICAL CANCER RESEARCH
- Src kinases as therapeutic targets for cancer
- (2009) Lori C. Kim et al. Nature Reviews Clinical Oncology
- Redox regulation of anoikis resistance of metastatic prostate cancer cells: key role for Src and EGFR-mediated pro-survival signals
- (2009) E Giannoni et al. ONCOGENE
- ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
- (2009) Y. Zong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gambogic Acid Inhibits Angiogenesis and Prostate Tumor Growth by Suppressing Vascular Endothelial Growth Factor Receptor 2 Signaling
- (2008) T. Yi et al. CANCER RESEARCH
- Targeting Src Family Kinases Inhibits Growth and Lymph Node Metastases of Prostate Cancer in an Orthotopic Nude Mouse Model
- (2008) S. I. Park et al. CANCER RESEARCH
- Aberrant Activation of Androgen Receptor in a New Neuropeptide-Autocrine Model of Androgen-Insensitive Prostate Cancer
- (2008) J. C. Yang et al. CANCER RESEARCH
- Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis
- (2008) M. P. Kim et al. CELL AND TISSUE RESEARCH
- Receptor activator of NF-κB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells
- (2008) Valerie A Odero-Marah et al. CELL RESEARCH
- Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model
- (2008) Haiyen E. Zhau et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
- (2008) Jing Yang et al. DEVELOPMENTAL CELL
- Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530
- (2008) Y-M Chang et al. ONCOGENE
- Src kinase potentiates androgen receptor transactivation function and invasion of androgen-independent prostate cancer C4-2 cells
- (2008) M Asim et al. ONCOGENE
- Multiple Oncogenic Pathway Signatures Show Coordinate Expression Patterns in Human Prostate Tumors
- (2008) Chad J. Creighton PLoS One
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search